European Journal of Medicinal Chemistry, volume 128, pages 79-87

Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors

Mateusz Daśko 1, 2, 3, 4
Maja Przybyłowska 1, 2, 3, 4
Janusz Rachon 1, 2, 3, 4
Majus Misiak 6
Andrzej Składanowski 6
Sebastian Demkowicz 1, 2, 3, 4
1
 
Faculty of Chemistry
3
 
Narutowicza 11/12 80-233 Gdansk Poland
4
 
Department of Organic Chemistry
5
 
Department of Molecular Biology Faculty of Biotechnology and Environment Sciences The John Paul II Catholic University of Lublin Konstantynów 1i 20‐708 Lublin Poland
Publication typeJournal Article
Publication date2017-03-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor6.7
ISSN02235234, 17683254
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Abstract
In the present work, we report convenient methods for the synthesis of 3-(4-aminophenyl)-coumarin-7-O-sulfamate derivatives N-acylated with fluorinated analogues of benzoic or phenylacetic acid as steroid sulfatase (STS) inhibitors. The design of these potential STS inhibitors was supported by molecular modeling techniques. Additionally, computational docking methods were used to determine the binding modes of the synthesized inhibitors and to identify potential interactions between inhibitors and amino acid residues located in the active site of STS. The inhibitory effects of the synthesized compounds were tested on STS isolated from human placenta and against estrogen receptor-(ER)-positive MCF-7 and T47D cells, as well as ER-negative MDA-MB-231 and SkBr3 cancer cell lines. In the course of our investigation, compounds 6c and 6j demonstrated the highest inhibitory effect in enzymatic STS assays, both with IC50 values of 0.18 μM (the IC50 value of coumarin-7-O-sulfamate is 1.38 μM, used as a reference). Compound 6j exhibited the highest potency against the MCF-7 and T47D cell lines (15.9 μM and 8.7 μM, respectively). The GI50 values of tamoxifen (used as a reference) were 6.8; 10.6; 15.1; 12.5 μM against MCF-7, T47D, MDA-MB-231 and SkBr3 cancer cell lines, respectively. Despite the slightly lower activity of compounds 1 and 2 (both in enzymatic and cell-based experiments) compared to 6g and 6j, analogues 1 and 2 proved to selectively inhibit the growth of ER- and PR-positive cell lines.

Top-30

Citations by journals

1
2
3
European Journal of Medicinal Chemistry
3 publications, 13.04%
Molecules
2 publications, 8.7%
RSC Advances
2 publications, 8.7%
Journal of Enzyme Inhibition and Medicinal Chemistry
2 publications, 8.7%
Current Topics in Medicinal Chemistry
1 publication, 4.35%
Current Organic Chemistry
1 publication, 4.35%
Applied Microbiology and Biotechnology
1 publication, 4.35%
Bioorganic Chemistry
1 publication, 4.35%
Bioorganic and Medicinal Chemistry
1 publication, 4.35%
Journal of Photochemistry and Photobiology A: Chemistry
1 publication, 4.35%
Drug Development Research
1 publication, 4.35%
Journal of Medicinal Chemistry
1 publication, 4.35%
Journal of Asian Natural Products Research
1 publication, 4.35%
Expert Opinion on Therapeutic Patents
1 publication, 4.35%
RSC Medicinal Chemistry
1 publication, 4.35%
Biomedicines
1 publication, 4.35%
Russian Chemical Reviews
1 publication, 4.35%
1
2
3

Citations by publishers

1
2
3
4
5
6
Elsevier
6 publications, 26.09%
Taylor & Francis
4 publications, 17.39%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 13.04%
Royal Society of Chemistry (RSC)
3 publications, 13.04%
Bentham Science
2 publications, 8.7%
Springer Nature
1 publication, 4.35%
Wiley
1 publication, 4.35%
American Chemical Society (ACS)
1 publication, 4.35%
OAE Publishing Inc.
1 publication, 4.35%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 4.35%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Daśko M. et al. Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors // European Journal of Medicinal Chemistry. 2017. Vol. 128. pp. 79-87.
GOST all authors (up to 50) Copy
Daśko M., Przybyłowska M., Rachon J., Masłyk M., Kubiński K., Misiak M., Składanowski A., Demkowicz S. Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors // European Journal of Medicinal Chemistry. 2017. Vol. 128. pp. 79-87.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ejmech.2017.01.028
UR - https://doi.org/10.1016/j.ejmech.2017.01.028
TI - Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors
T2 - European Journal of Medicinal Chemistry
AU - Daśko, Mateusz
AU - Przybyłowska, Maja
AU - Rachon, Janusz
AU - Masłyk, Maciej
AU - Kubiński, Konrad
AU - Misiak, Majus
AU - Składanowski, Andrzej
AU - Demkowicz, Sebastian
PY - 2017
DA - 2017/03/01 00:00:00
PB - Elsevier
SP - 79-87
VL - 128
SN - 0223-5234
SN - 1768-3254
ER -
BibTex
Cite this
BibTex Copy
@article{2017_Daśko,
author = {Mateusz Daśko and Maja Przybyłowska and Janusz Rachon and Maciej Masłyk and Konrad Kubiński and Majus Misiak and Andrzej Składanowski and Sebastian Demkowicz},
title = {Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors},
journal = {European Journal of Medicinal Chemistry},
year = {2017},
volume = {128},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/j.ejmech.2017.01.028},
pages = {79--87},
doi = {10.1016/j.ejmech.2017.01.028}
}
Found error?